Seres Therapeutics Inc (MCRB)

Aug 10, 2025

Seres Therapeutics Inc. Bounces Off Moving Average SupportReal Trader Watchlist of Hot Stocks Released - metal.it

Aug 10, 2025

Aug 09, 2025

Seres (MCRB) Q2 Loss Narrows 34% - AOL.com

Aug 09, 2025

Aug 07, 2025

Seres Therapeutics’ Earnings Call: Progress Amid Challenges - TipRanks

Aug 07, 2025

Aug 07, 2025

Promising Developments and Strategic Partnerships Drive Buy Rating for Seres Therapeutics - TipRanks

Aug 07, 2025

Aug 07, 2025

Seres Therapeutics outlines global Phase II SER-155 trial with 248-patient enrollment amid partnership talks - MSN

Aug 07, 2025

Aug 07, 2025

Seres Therapeutics Reports Q2 2025 Financial Results - TipRanks

Aug 07, 2025

Aug 07, 2025

Seres Therapeutics: Q2 Earnings Snapshot - Connecticut Post

Aug 07, 2025

Aug 06, 2025

Seres Therapeutics: Unpacking Strategic Contradictions in Partnerships and FDA Engagements - AInvest

Aug 06, 2025

Aug 06, 2025

Seres Therapeutics, Inc. 2025 Q2ResultsEarnings Call Presentation (NASDAQ:MCRB) - Seeking Alpha

Aug 06, 2025

Aug 06, 2025

Sana Biotechnology shares fall 14.12% after-hours following Seres Therapeutics' board changes and clinical advancement updates. - AInvest

Aug 06, 2025

Aug 06, 2025

Seres Therapeutics, Inc. SEC 10-Q Report - TradingView

Aug 06, 2025

Aug 06, 2025

Earnings call transcript: Seres Therapeutics reports larger-than-expected Q2 loss By Investing.com - Investing.com South Africa

Aug 06, 2025

Aug 06, 2025

Earnings call transcript: Seres Therapeutics reports larger-than-expected Q2 loss - Investing.com

Aug 06, 2025

Aug 06, 2025

Seres Therapeutics quarterly loss per share $2.27 - MarketScreener

Aug 06, 2025

Aug 06, 2025

Seres Therapeutics August 2025 slides: SER-155 shows 77% infection reduction - Investing.com

Aug 06, 2025

Aug 06, 2025

Nxera debuts an obesity pipeline; BridgeBio battles Alynam for market share - Yahoo Finance

Aug 06, 2025

Aug 06, 2025

Seres Therapeutics: A High-Conviction Biotech Buy Amid Clinical and Strategic Momentum - AInvest

Aug 06, 2025

Aug 06, 2025

Seres Therapeutics Reports Second Quarter 2025 Financial Results - GuruFocus

Aug 06, 2025

Aug 06, 2025

Seres Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Updates - Yahoo Finance

Aug 06, 2025

Aug 04, 2025

Seres Therapeutics Inc. Stock Analysis and ForecastAchieve consistent profits with proven methods - Jammu Links News

Aug 04, 2025

Aug 03, 2025

Is Seres Therapeutics Inc. a growth stock or a value stockRapid portfolio appreciation - Jammu Links News

Aug 03, 2025

Aug 03, 2025

Is Seres Therapeutics Inc. a good long term investmentAchieve breakthrough gains with smart trades - Jammu Links News

Aug 03, 2025

Aug 03, 2025

How does Seres Therapeutics Inc. compare to its industry peersMaximize your portfolio’s growth potential - Jammu Links News

Aug 03, 2025

Aug 03, 2025

What are Seres Therapeutics Inc. company’s key revenue driversConsistent high-yield stocks - Jammu Links News

Aug 03, 2025

Aug 03, 2025

When is Seres Therapeutics Inc. stock expected to show significant growthInvest confidently with real-time data - Jammu Links News

Aug 03, 2025

Aug 03, 2025

What are analysts’ price targets for Seres Therapeutics Inc. in the next 12 monthsBuild a diversified portfolio for maximum returns - Jammu Links News

Aug 03, 2025

Aug 03, 2025

Should I hold or sell Seres Therapeutics Inc. stock in 2025Build a portfolio that grows with the market - Jammu Links News

Aug 03, 2025

Aug 02, 2025

What analysts say about Seres Therapeutics Inc. stockUnmatched profit potential - Jammu Links News

Aug 02, 2025

Aug 02, 2025

What makes Seres Therapeutics Inc. stock price move sharplyBuild wealth with steady, reliable stocks - Jammu Links News

Aug 02, 2025

Aug 01, 2025

Why is Seres Therapeutics Inc. stock attracting strong analyst attentionRetirement Planning Entry Points For Consistent Profits - Jammu Links News

Aug 01, 2025

Jul 29, 2025

Is Seres Therapeutics Inc. Stock a Smart Buy in 2025 Investment Analysis Inside - metal.it

Jul 29, 2025

Jul 29, 2025

Seres Therapeutics: Speculative Gem with FDA Breakthrough Potential - AInvest

Jul 29, 2025

Jul 29, 2025

Seres Therapeutics: Speculative Gem Backed By SER‑155 FDA Breakthrough - Seeking Alpha

Jul 29, 2025

Jul 29, 2025

Why Seres Therapeutics Inc. stock attracts strong analyst attentionEntry Zone Strategy for Consistent Profit Shared - metal.it

Jul 29, 2025

Jul 28, 2025

What institutional investors are buying Seres Therapeutics Inc. stockPhenomenal wealth increase - Jammu Links News

Jul 28, 2025

Jul 28, 2025

How many analysts rate Seres Therapeutics Inc. as a “Buy”Build wealth with reliable stock picks - Jammu Links News

Jul 28, 2025

Jul 28, 2025

Will Seres Therapeutics Inc. Recover After Recent DeclineStock Market Entry Timing Signals Revealed - metal.it

Jul 28, 2025

Jul 28, 2025

What is the dividend policy of Seres Therapeutics Inc. stockSkyrocketing returns - Jammu Links News

Jul 28, 2025